JP2021038271A5 - - Google Patents

Download PDF

Info

Publication number
JP2021038271A5
JP2021038271A5 JP2020205127A JP2020205127A JP2021038271A5 JP 2021038271 A5 JP2021038271 A5 JP 2021038271A5 JP 2020205127 A JP2020205127 A JP 2020205127A JP 2020205127 A JP2020205127 A JP 2020205127A JP 2021038271 A5 JP2021038271 A5 JP 2021038271A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020205127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021038271A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021038271A publication Critical patent/JP2021038271A/ja
Publication of JP2021038271A5 publication Critical patent/JP2021038271A5/ja
Pending legal-status Critical Current

Links

JP2020205127A 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置 Pending JP2021038271A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462005558P 2014-05-30 2014-05-30
US201462005652P 2014-05-30 2014-05-30
US62/005,558 2014-05-30
US62/005,652 2014-05-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017515014A Division JP6810028B2 (ja) 2014-05-30 2015-05-28 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Publications (2)

Publication Number Publication Date
JP2021038271A JP2021038271A (ja) 2021-03-11
JP2021038271A5 true JP2021038271A5 (enExample) 2021-11-25

Family

ID=54699800

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017515014A Active JP6810028B2 (ja) 2014-05-30 2015-05-28 組換え片利共生皮膚微生物による皮膚疾患の治療処置
JP2020205127A Pending JP2021038271A (ja) 2014-05-30 2020-12-10 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017515014A Active JP6810028B2 (ja) 2014-05-30 2015-05-28 組換え片利共生皮膚微生物による皮膚疾患の治療処置

Country Status (6)

Country Link
US (3) US10702558B2 (enExample)
EP (2) EP4144756A1 (enExample)
JP (2) JP6810028B2 (enExample)
ES (1) ES2929579T3 (enExample)
MA (1) MA40057A (enExample)
WO (1) WO2015184134A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA40057A (fr) 2014-05-30 2015-12-03 Azitra Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants
AU2017254684A1 (en) 2016-04-21 2018-12-06 Weiss Bioscience, Inc. Compositions and methods for treatment of skin disorders
EP3638369A4 (en) * 2017-06-16 2021-03-17 Azitra, Inc. COMPOSITIONS AND METHODS OF TREATING NETHERTON'S SYNDROME WITH LEKTI-EXPRESSING RECOMBINANT MICROBES
BR112020003508A2 (pt) * 2017-08-31 2020-09-01 The Regents Of The University Of California polipeptídeo purificado, formulação tópica, polinucleotídeo isolado, vetor, microrganismo recombinante, composição probiótica tópica, composição medicamentosa, e, métodos de tratamento de um transtorno dermatológico, de tratamento de uma doença ou transtorno de pele e para liberação de fármacos através da pele.
KR102834865B1 (ko) * 2017-09-05 2025-07-17 아지트라 인코포레이티드 재조합 미생물을 사용하여 염증성 피부 질환을 치료하기 위한 방법 및 조성물
AU2018379996A1 (en) 2017-12-05 2020-06-25 BioPlx, Inc. Methods and compositions to prevent microbial infection
JP7121969B2 (ja) * 2018-02-23 2022-08-19 株式会社北里コーポレーション 培養液保護用液状物
KR20200139760A (ko) * 2018-04-05 2020-12-14 아지트라 인코포레이티드 재조합 미생물을 사용하여 피부 질환을 치료하기 위한 방법 및 조성물
AU2019203692B2 (en) * 2018-08-30 2024-12-12 Kenvue Brands Llc Topical composition containing glycerin and yeast extract
JP7560449B2 (ja) * 2018-09-26 2024-10-02 クリスタル バイオテック インコーポレイテッド 皮膚疾患の治療のための組成物及び方法
WO2020076770A1 (en) * 2018-10-08 2020-04-16 Yale University Selective binding and aggregation of human keratin in the skin barrier using human filaggrin subdomains sd67 and sd150
AU2019378003A1 (en) * 2018-11-16 2021-05-20 Azitra Inc Auxotrophic strains of Staphylococcus bacterium
CZ308231B6 (cs) * 2019-02-11 2020-03-11 BiomCare s.r.o. Kombinované několikastupňové mikrobiální přípravky a způsob jejich aplikace
EP3946412A4 (en) * 2019-04-05 2023-01-04 Azitra, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF ATOPIC DERMATITIS WITH RECOMBINANT MICROORGANISMS
JP2022537045A (ja) * 2019-06-19 2022-08-23 チャン ザッカーバーグ バイオハブ, インコーポレイテッド 抗原特異的t細胞を誘発するために操作された細菌
JP2023512215A (ja) * 2020-01-29 2023-03-24 ザ ジャクソン ラボラトリー 細菌混和物
US20240010970A1 (en) * 2020-10-21 2024-01-11 The Jackson Laboratory Antimicrobial biosensors
JP2024506463A (ja) * 2021-01-05 2024-02-14 ラクトバイオ アー/エス 菌株、組成物および使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0637384B2 (ja) 1985-09-21 1994-05-18 株式会社資生堂 皮膚化粧料
US4659774A (en) 1985-11-01 1987-04-21 American Hoechst Corporation Support for solid-phase oligonucleotide synthesis
DE4221255C2 (de) 1992-06-26 1994-09-15 Lancaster Group Ag Phospholipide enthaltendes Kosmetikum
DE4221268C2 (de) 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
CA2775111C (en) 2009-09-25 2019-12-31 Opko Curna, Llc Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
CA2781537C (en) 2009-11-23 2022-06-28 Research Development Foundation Recombinant filaggrin polypeptides for cell importation
WO2011150127A2 (en) * 2010-05-25 2011-12-01 The Board Of Trustees Of The University Of Illinois Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
KR20150065170A (ko) * 2012-08-07 2015-06-12 탑제닉스, 인크. 관심있는 화합물을 발현하는 형질전환된 박테리아를 포함하는 국소 조성물
KR101491240B1 (ko) 2013-03-15 2015-02-11 현대자동차주식회사 인비저블 슬라이딩 도어 링크 구조
MA40057A (fr) 2014-05-30 2015-12-03 Azitra Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants

Similar Documents

Publication Publication Date Title
JP2022028828A5 (enExample)
JP2022025124A5 (enExample)
JP2021185136A5 (enExample)
JP2021169491A5 (enExample)
JP2022068302A5 (enExample)
JP2021028398A5 (enExample)
JP2023116721A5 (enExample)
JP2021038271A5 (enExample)
JP2021184963A5 (enExample)
JP2023022224A5 (enExample)
JP2024059739A5 (enExample)
JP2020127428A5 (enExample)
JP2020042034A5 (enExample)
JP2024016014A5 (enExample)
JP2020530297A5 (enExample)
JP2019099571A5 (enExample)
JP2019030304A5 (enExample)
JP2021502066A5 (enExample)
JP2022060295A5 (enExample)
JP2023100643A5 (enExample)
JP2020120660A5 (enExample)
JP2018154848A5 (enExample)
JP2019031552A5 (enExample)
JP2020171301A5 (enExample)
JP2022022379A5 (enExample)